The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs

Citation
E. Adriaens et al., The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs, PHARM RES, 18(7), 2001, pp. 937-942
Citations number
22
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACEUTICAL RESEARCH
ISSN journal
07248741 → ACNP
Volume
18
Issue
7
Year of publication
2001
Pages
937 - 942
Database
ISI
SICI code
0724-8741(200107)18:7<937:TMTODB>2.0.ZU;2-8
Abstract
Purpose. The objective of this study was to evaluate the mucosal toxicity o f different benzalkonium chloride (BAC) analogues using slugs as the altern ative test organism. Methods. The effect of different BAC analogues on the mucosal tissue of slu gs was determined from the protein, lactate dehydrogenase, and alkaline pho sphatase released from the foot mucosa after treatment. Additionally, mucus production and reduction in body weight of the slugs were measured. The ey e irritation potency of the molecules was evaluated with the Bovine Corneal Opacity and Permeability (BCOP) assay. The antimicrobial activity of the d ifferent BAC analogues was also assessed. Results. All BAC analogues induced severe damage to the mucosal epithelium of the slugs, and the irritation increased with decreasing alkyl chain leng th: BAC-C16 < BAC-C14 < BAC-C12 similar to BAG-mix. A similar ranking was o btained with the BCOP assay for eye irritation. The relative order of activ ities among the three BAC analogues was the same, i.e., BAC-C14 greater tha n or equal to BAC-C16 > BAC-C12. The BAC-C14 exhibited higher activity than the BAG-mix. Conclusions. The toxicity and activity of BAG analogues depend on the alkyl chain length. The use of BAC-C14 as a conservative agent in pharmaceutical preparations instead of the BAG-mix should be considered.